[Treatment of myasthenia gravis pseudoparalytica].
D009157:Myasthenia Gravis / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D025101:Vitamin B 6 / Q000627:therapeutic use*
D011725:Pyridines; D009388:Neostigmine; D025101:Vitamin B 6
MYASTHENIA GRAVIS/therapy; NEOSTIGMINE/therapeutic use; PYRIDINES/therapeutic use; VITAMIN B6/therapeutic use
Die Behandlung der Myasthenia gravis pseudoparalytica.